Release Summary

Blaze Bioscience Announces Presentation of Tumor Paint BLZ-100 Clinical Data at ASBrS Annual Meeting. First presentation of Tumor Paint BLZ-100 Phase 1 breast cancer data.

Blaze Bioscience, Inc.